Penile squamous cell carcinoma (PSCC) represents a malignancy with low incidence. Despite advances in chemotherapy-based management, outcomes for patients with locally advanced and metastatic disease remain poor, with 5-year survival rates of 51% and 9%, respectively. Early diagnosis is crucial, yet psychosocial/structural barriers often delay it. Treatment strategies are stage-dependent, ranging from organ-sparing surgery and targeted radiotherapy for early-stage disease to cisplatin-based chemotherapy for locally advanced and metastatic cases. However, systemic therapies provide modest survival benefits and can expose the patient to unnecessary toxicities. Immunotherapy has emerged as a promising area, given the high expression of PD-L1 in PSCC and the significant proportion of HPV-driven tumors. Although initial results from immunotherapy-based trials are limited, preliminary trials such as HERCULES, ALPACA, PULSE, and PERICLES aim to define their role better. Similarly, combination regimens utilizing toripalimab in combination with nimotuzumab and taxane-based chemotherapy (TNT) followed by consolidative surgery are currently underway. Furthermore, the development of therapeutic HPV vaccines offers a novel strategy to enhance local antitumor immunity. Antibody–drug conjugates (ADCs) targeting HER-2, Trop-2, and Nectin-4 antigens represent another evolving therapeutic avenue that has shown preliminary promising results. As the landscape of penile cancer treatment continues to grow, incorporating these novel strategies could further improve survival outcomes and/or offer improved quality of life. This review provides a comprehensive overview of emerging systemic therapies in PSCC, underscoring ongoing research efforts to address unmet needs.
10 September 2026 in International Journal Of Impotence Research
Purpose of Review: Partial nephrectomy has become the preferred treatment for localized renal masses, particularly in the minimally invasive surgery (MIS) era. However, outcomes depend not only on the surgical approach but also on how each step of the procedure is performed. This review examines the key technical steps and clinical determinants that influence oncologic control, renal functional preservation, and perioperative morbidity in contemporary minimally invasive partial nephrectomy. Recent findings: Recent evidence highlights the importance of assessing tumor complexity, tailoring ischemia strategies, and selecting resection techniques that maximize parenchymal preservation. Advances in intraoperative imaging, three-dimensional planning, and fluorescence guidance have improved surgical precision and supported more informed intraoperative decision-making. Comparative studies also suggest that techniques such as tumor enucleation and selective clamping can help preserve renal function without compromising oncologic outcomes in appropriately selected patients. Summary: Current evidence suggests that outcomes after PN depend largely on tumor characteristics, patient factors, and the way the operation is performed, rather than on the surgical platform itself. Achieving optimal results requires careful preoperative planning, precise surgical technique, and adequate experience. Ongoing advances in imaging integration and intraoperative guidance technologies may further support surgical decision-making and help improve renal functional preservation in nephron-sparing surgery (NSS).
9 July 2026 in Urologic Oncology: Seminars and Original Investigations
Penile cancer is an uncommon yet aggressive disease, especially at advanced stages. Management can be morbid, and patients often face a significant psychosocial impact alongside a lack of patient advocacy/support system in most parts of the globe. Local treatments can preserve penile function and provide acceptable oncologic control in selected patients. The use of organ-sparing treatments is higher in experienced centers, where adherence to guidelines is greater. Inguinal lymph node dissection remains essential in the management of this disease as it is both diagnostic and therapeutic. Several modifications to the initially described technique have been proposed with the intention of decreasing the morbidity of this procedure, which is approximately 30% for all comers. However, lack of standardization on the complication reporting and limited high-quality evidence further hinders progress in this field. For locally advanced and metastatic disease, the combination of paclitaxel, ifosfamide, and cisplatin (TIP) chemotherapy is the gold standard. However, this regimen offers limited benefit in advanced stages. In contrast, chemoimmunotherapy and other systemic therapies show promising results in a few small prospective, single-arm trials several of which are still under investigation. The objective of this manuscript is to synthesize evidence on the 4 main unment needs in penile cancer: patient advocacy/quality of life, local/organ-sparing treatment, inguinal lymph node dissection (ILND), and systemic therapy, highlighting gaps in clinical care and research priorities. A focused effort in those areas is needed to advance further patient care, quality of life, and their ability to navigate this disease.
Renal cell carcinoma (RCC) is an aggressive kidney cancer often diagnosed at an advanced stage. This type of kidney tumor can be associated with tumor thrombus (TT), which can extend into the inferior vena cava (IVC) and, in severe cases, into the right side of the heart. Managing RCC with TT is particularly complex when extension of the TT into the right heart is present, as the use of intraoperative transesophageal echocardiography (TEE) and cardiopulmonary bypass (CPB) aid in performing a complete TT surgical resection. In terms of tumor neo-vessels, solid tumors such as RCC-TT depend on a vascularized connective tissue stroma for growth, proliferation and malformation which are supported by various factors promoting these processes. Herein, we present the case of a 69-year-old patient with a right renal tumor with a TT extending through the IVC up into the right side of the heart. During the surgery, a segment of the TT embolized into the pulmonary arteries, highlighting the surgical challenges, the use of CPB, and TEE in managing such cases, as well as discussing the implications of finding blood vessels inside the TT.